The Global Acne Treatment Market size was estimated at USD 5.9 Bn in 2021, growing at a CAGR of 4.9% during the forecast period 2021-2027. The acne treatment market report gives the comprehensive outlook on acne treatment options across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report gives historical, current, and future market sizes (US$ Mn) of product types, medication type, acne types, route of administration, distribution channels, and geographic regions. This report studies acne treatment market dynamics elaborately to identify the current trends & drivers, future market opportunities and possible challenges to the key stakeholders operating in the market. The change in lifestyle of millennial and Gen X populations has changed the social habits of the young population, which is considered as the factor for early onset of acne among the young population. The early onset of acne in younger population prompts the patients to seek the various treatments for acne that in turn increases the demand for acne treatment product in the market. Moreover, psychological effects associated with acne such as anxiety and depression in a young patient pool is expected to create demand for OTC acne products over the forecast period. Several publications noted that psychological burden is very high among acne sufferers, which has created the better market opportunity for market players across the globe. Market players are focusing on mergers and acquisitions to improve their market position in acne treatment market. For instance, in 2014, Nestlé acquired Galderma S.A., a dermatology company, to strengthen market position. Moreover, market players are launching generic versions to gain larger market revenue share. For instance, in July 2017, Teva launched generic version of Epiduo (adapalene and benzoyl peroxide) gel 0.1%/2.5% in the US for the treatment of acne.